1. Home
  2. BETR vs IMRX Comparison

BETR vs IMRX Comparison

Compare BETR & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Better Home & Finance Holding Company

BETR

Better Home & Finance Holding Company

N/A

Current Price

$13.55

Market Cap

334.8M

Sector

Finance

ML Signal

N/A

IMRX

Immuneering Corporation

N/A

Current Price

$5.23

Market Cap

288.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BETR
IMRX
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.8M
288.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BETR
IMRX
Price
$13.55
$5.23
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$40.00
$17.20
AVG Volume (30 Days)
677.0K
667.6K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
20.88
37.75
EPS
N/A
N/A
Revenue
$164,872,000.00
N/A
Revenue This Year
$55.02
N/A
Revenue Next Year
$65.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
51.97
N/A
52 Week Low
$13.18
$3.25
52 Week High
$94.06
$10.08

Technical Indicators

Market Signals
Indicator
BETR
IMRX
Relative Strength Index (RSI) 33.79 63.48
Support Level N/A $4.82
Resistance Level $28.72 $5.27
Average True Range (ATR) 2.31 0.22
MACD -0.44 0.11
Stochastic Oscillator 1.89 92.56

Price Performance

Historical Comparison
BETR
IMRX

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: